Concepedia

Author

Michal Juraska

Fred Hutch Cancer CenterORCID

Also Known As

Bailey Jordan, Connolly, Kristen M., Corey, L., Corey, Lawrence, Eaton, A., Frank, I., Gilbert, P.B., Han, S., Huang, Y., Juraska, M.

91

Publications

2.8K

Citations

23

H-Index

46

Concepts

All Affiliations

Fred Hutch Cancer CenterUniversity of WashingtonNational Institute of Allergy and Infectious DiseasesEmory UniversityUniversity of North Carolina at Chapel Hill
MJ

About

Michal Juraska is an author at Fred Hutch Cancer Center specializing in medicine, immunology, and epidemiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

12

12

956

2

Epidemiology

7

7

420

3

Public Health

5

5

269

4

Biostatistics

4

4

155

5

Engineering

1

1

12

Michal Juraska

×

35

Publications

2.7K

Citations

22

H-Index

YearCitations

Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

Lawrence Corey, Peter B. Gilbert, Michal Juraska,

New England Journal of Medicine

2021

492

Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine

Daniel E. Neafsey, Michal Juraska, Trevor Bedford,

New England Journal of Medicine

2015

437

Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2

Morgane Rolland, Paul T. Edlefsen, Brendan B. Larsen,

Nature

2012

420

Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials

Devan V. Mehrotra, Holly Janes, Thomas R. Fleming,

Annals of Internal Medicine

2020

114

Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition

Peter B. Gilbert, Yunda Huang, Allan C. deCamp,

Nature Medicine

2022

105

Neutralizing Antibody Correlates Analysis of Tetravalent Dengue Vaccine Efficacy Trials in Asia and Latin America

Zoe Moodie, Michal Juraska, Ying Huang,

The Journal of Infectious Diseases

2017

98

Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials

Peter B. Gilbert, Michal Juraska, Allan C. deCamp,

Statistical Communications in Infectious Diseases

2017

95

Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs

Joseph R. Francica, Daniel E. Zak, Caitlyn Linde,

Blood Advances

2017

90

Viral genetic diversity and protective efficacy of a tetravalent dengue vaccine in two phase 3 trials

Michal Juraska, Craig A. Magaret, Jason Shao,

Proceedings of the National Academy of Sciences

2018

81

Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120

Allan C. deCamp, Morgane Rolland, Paul T. Edlefsen,

PLoS ONE

2017

70

Page 1